5-ALA and FDA approval for glioma surgery

Hadjipanayis, CG; Stummer, W

Hadjipanayis, CG (reprint author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.; Hadjipanayis, CG (reprint author), Mt Sinai Beth Israel, Dept Neurosurg, New York, NY 10003 USA.

JOURNAL OF NEURO-ONCOLOGY, 2019; 141 (3): 479

Abstract

The US Food and Drug Administration (FDA) approved 5-aminolevulinic acid (5-ALA; Gleolan((R)); photonamic GmbH and Co. KG) for use as an intraoperativ......

Full Text Link